Your browser doesn't support javascript.
loading
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease.
Pellecchia, M T; Santangelo, G; Picillo, M; Pivonello, R; Longo, K; Pivonello, C; Vitale, C; Amboni, M; De Rosa, A; Moccia, M; Erro, R; De Michele, G; Santoro, L; Colao, A; Barone, P.
Affiliation
  • Pellecchia MT; Center for Neurodegenerative Diseases, University of Salerno, Salerno, Italy.
Eur J Neurol ; 21(5): 802-7, 2014 May.
Article in En | MEDLINE | ID: mdl-23551560
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Insulin-Like Growth Factor I / Cognition Disorders Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Eur J Neurol Journal subject: NEUROLOGIA Year: 2014 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Insulin-Like Growth Factor I / Cognition Disorders Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Eur J Neurol Journal subject: NEUROLOGIA Year: 2014 Document type: Article Affiliation country: Country of publication: